Publications by authors named "Heidi Altmann"

Claim this Profile
F
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.
Melissa Zwick, Bastian Zinkel, Corinna Spohr, Tamina Rückert, Sebastian Halbach, Heidi Altmann

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.
Richard J Pelzl, Giulia Benintende, Franziska Gsottberger, Julia K Scholz, Matthias Ruebner, Heidi Altmann

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study.
Elke Rücker-Braun, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Heidi Altmann

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.
Leo Ruhnke, Marius Bill, Sven Zukunft, Jan-Niklas Eckardt, Silvia Schäfer, Heidi Altmann

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating Centralized Biobanking Workflows for NMR Metabolomics Using the PRIMA Panel.
Heidi Altmann, Marko Barovic, Katrin Straßburger, Maximilian Tschäpel, Sophie Jonas

Anal Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy.
Ulf Schnetzke, Mike Fischer, Christoph Röllig, André Scherag, Heidi Altmann

Genes Immun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue factor binds to and inhibits interferon-α receptor 1 signaling.
Jayakumar Manoharan, Rajiv Rana, Georg Kuenze, Dheerendra Gupta, Ahmed Elwakiel, Heidi Altmann

Immunity· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, Lianghao Mao, Lavanya Mokada Gopal, Heidi Altmann

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.
Nora Liebers, Peter-Martin Bruch, Tobias Terzer, Miguel Hernandez-Hernandez, Nagarajan Paramasivam, Heidi Altmann

Nat Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.
Falk Heidenreich, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Heidi Altmann

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation in modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Stephan Buch, Hamish Innes, Philipp Ludwig Lutz, Hans Dieter Nischalke, Jens U Marquardt, Heidi Altmann

Gut· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation.
Yannick F Fuchs, Jonathan Brunner, Marc Weigelt, Anja Schieferdecker, Robert Morgenstern, Heidi Altmann

Biopreserv Biobank· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.
Friedrich Stölzel, Sarah E Fordham, Devi Nandana, Wei-Yu Lin, Helen Blair, Heidi Altmann

JCI Insight· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19.
Nikolai P Jaschke, Alexander M Funk, Sophie Jonas, Romy M Riffel, Anupam Sinha, Heidi Altmann

J Clin Endocrinol Metab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung-On Yau, Heidi Altmann

J Clin Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Heidi Altmann

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Heidi Altmann

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.
Enrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, Anja Hoffmann, Ralf Bergmann, Heidi Altmann

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of mutations - a registry based analysis.
Jan M Middeke, Raphael Teipel, Christoph Röllig, Sebastian Stasik, Armin Zebisch, Heidi Altmann

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
Leo Ruhnke, Friedrich Stölzel, Lisa Wagenführ, Heidi Altmann, Uwe Platzbecker

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML.
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E Church, Tressa Hood, Heidi Altmann

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.
Desiree Kunadt, Christian Dransfeld, Claudia Dill, Maria Schmiedgen, Michael Kramer, Heidi Altmann

Ann Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia.
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, Sarah E Church, Stephen Reeder, Heidi Altmann

Sci Transl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia.
Desiree Kunadt, Michael Kramer, Claudia Dill, Heidi Altmann, Lisa Wagenführ

Biomark Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia.
Frederick Fasslrinner, Claudia Arndt, Stefanie Koristka, Anja Feldmann, Heidi Altmann

Br J Haematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis